(Press-News.org) Scientists at The University of Manchester have created an enhanced surface for silicone breast implants which could reduce complications and make them less likely to be rejected by the body.
In the US alone almost 400,000 cosmetic breast augmentations and reconstructions are carried out each year, and the number is growing. Some of these cases are for reconstruction after surgery for breast cancer and can have important psychological benefits.
However, around one in five people who has a breast implant suffers from capsular contracture where scar tissue forms and can shrink after the surgery - causing pain, deformity and the need for further surgery. Fluid from the body can also build up, (known as a seroma) and the scar tissue can also cause leaks in the implants.
Capsular contracture is caused by the body resisting the implantation of a foreign object. It has previously been shown that rougher surfaces (also known as textured surfaces) reduce the amount of scar tissue formed around breast implants, but the Manchester scientists felt that they could improve this by creating a pattern which mimicked body's own surface, such as the basal layer of the skin, providing a better environment for the cells to grow on.
"The surfaces of breast implants in use today have relatively large features on their surface, which have no discernible correlation with biological features required for cells to interact with. Importantly, the micro environment created by the features of a breast implant is critical for breast tissue cells to adhere to that surface and grow on," said Dr Ardeshir Bayat, from the University's Institute of Inflammation and Repair, who led the study.
"Compared to the size of the cells, these bumps on existing implants are so large that they're effectively a smooth cliff face compared to the dimensions required for the cell to interact with.
"Our approach was to create a novel surface which mimics the basal layer of the skin, which the body's cells are more likely to recognise and interact with favourably."
The tests were carried out in the lab over a period of one week - a critical early period after surgery, and while the researchers acknowledge that much more work is yet to be done, the new surface reduced the foreign body reaction of the cells when compared to the smooth and larger textured surfaces currently available on the market.
These findings suggest that it this unique surface may help to reduce the likelihood of adverse inflammation and subsequent scarring in the form of so-called breast capsular fibrosis.
Dr Bayat added: "Some of the surfaces seen on implants today were designed originally in the 60s and 70s and therefore there is an unmet need for delivering the next generation of biomimetic breast implant surfaces.
"The original designers found that surface features so-called 'bumps' on the existing surfaces had an adverse effect, but what we did was to reduce the size, dimension and appearance of these bumps down from the size of say, a hill, to that of a pebble.
"This makes interaction at the cellular level much better. Nevertheless, we need to do a lot more work to bring this to the clinic, and the increasing numbers of women having these operations means, that it is an important process to go through."
The study: 'Development and functional evaluation of biomimetic silicone surfaces with hierarchical micro/nano-topographical features demonstrates favourable in vitro foreign body response of breast-derived fibroblasts' was published in the journal, Biomaterials.
A new research project from the University of Copenhagen has established an effective model for the fight against the escalating burden of tooth decay among children in Asia. The model is an important tool in breaking the social inequity in oral health of children.
In developing countries, the number of children who suffer pain and discomfort in addition to missing out on school lessons is increasing. This project demonstrates that the school is a vital key to better oral health. The project also shows how it is possible to organize school oral health intervention, including ...
(March 19, 2015, Abu Dhabi, UAE) -The Tobacco Atlas, Fifth Edition ("The Atlas"), and its companion mobile app and website TobaccoAtlas.org, were unveiled today by the American Cancer Society and World Lung Foundation at the 16th World Conference on Tobacco or Health. The Atlas graphically details the scale of the tobacco epidemic; the harmful influence of tobacco on health, poverty, social justice, and the environment; the progress being made in tobacco control; and the latest products and tactics being used by the industry to protect its profits and delay and derail tobacco ...
When patients develop acute liver failure, severe complications arise rapidly after the first signs of liver disease, and patients' health can deteriorate rapidly. New research published in the American Journal of Transplantation indicates that emergency evaluations of living liver donors can be conducted safely to allow acute liver failure patients to undergo transplantation before their condition worsens.
If untreated, acute liver failure results in coma and death in more than 80 percent of cases. The only effective therapy is liver transplantation, but the deceased ...
A Los Angeles ordinance designed to curb obesity in low-income areas by restricting the opening of new fast-food restaurants has failed to reduce fast-food consumption or reduce obesity rates in the targeted neighborhoods, according to a new RAND Corporation study.
Since the fast-food restrictions were passed in 2008, overweight and obesity rates in South Los Angeles and other neighborhoods targeted by the law have increased faster than in other parts of the city or other parts of the county, according to findings published online by the journal Social Science & Medicine.
Using melatonin could provide more and better quality sleep compared to using an eye mask and earplugs in a simulated noisy and illuminated environment, according to research published in open access journal Critical Care. This study was carried out on healthy subjects but could have future implications for intensive care unit (ICU) patients.
Melatonin is the hormone secreted by the body to regulate sleep, usually in periods of darkness. Synthetically produced melatonin is used to boost the body's own melatonin levels to treat some sleep disorders, and sometimes as a ...
The number of people living with cystic fibrosis into adulthood is expected to increase dramatically by 2025, prompting calls for the development of adult cystic fibrosis services to meet the demand.
People living with cystic fibrosis have previously had low life expectancy, but improvements in treatments and care in the last three decades have led to an increase in survival with almost all children now living to around 40 years.
In the first study of its kind, published in the European Respiratory Journal today (19 March 2015), researchers have provided forecasts ...
Introduction of standardised packaging for tobacco products in Australia prompted more smokers to think about quitting and to attempt to quit, show findings of surveys of adults smokers published in Tobacco Control.
In introducing standardised tobacco packaging with large graphic health warnings in December 2012, the Australian government's main aim was to reduce the attractiveness and appeal of tobacco products to young people and so reduce the likelihood of them taking up smoking.
In other studies the researchers from Melbourne in Victoria found that standardised ...
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that in women who have developed gestational diabetes mellitus (GDM) during pregnancy, being obese before the pregnancy and putting on more weight after it massively increases the risk of later developing type 2 diabetes (T2D).
For women who are obese before pregnancy (BMI 30 or higher) and put on 5 kg or more after giving birth, the risk of developing T2D is 43 times higher than for women who remain lean before pregnancy and gain 5 kg or less. The research, ...
A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell transplant survived without the disease progressing for twice as long as those given placebo (43 months vs 24 months).
The findings, published in The Lancet, are potentially practice changing for this young cancer population who have exhausted other treatment options and for whom prognosis is poor.
"No medication available today has had such dramatic results in patients with ...
EAST LANSING, Mich. - Malaria kills a child every minute. While medical researchers have successfully developed effective drugs to kill the malaria parasite, efforts to treat the effects of the disease have not been as successful. But that soon may change.
In a groundbreaking study published in the New England Journal of Medicine, Michigan State University's Dr. Terrie Taylor and her team discovered what causes death in children with cerebral malaria, the deadliest form of the disease.
"We discovered that some children with cerebral malaria develop massively swollen ...